These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16421740)

  • 1. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
    Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
    Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
    J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and colocalization of choline acetyltransferase immunoreactivity and NADPH diaphorase reactivity in neurons within the medial septum and diagonal band of Broca in the rat basal forebrain.
    Kitchener PD; Diamond J
    J Comp Neurol; 1993 Sep; 335(1):1-15. PubMed ID: 8408771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related vulnerability of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus.
    Burke MA; Apter JR; Wainer BH; Mufson EJ; Kordower JH
    Exp Neurol; 1994 Aug; 128(2):159-71. PubMed ID: 7521302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor receptor expressing human basal forebrain neurons: pathologic alterations in Alzheimer's and Parkinson's disease.
    Mufson EJ; Kordower JH
    Prog Clin Biol Res; 1989; 317():401-14. PubMed ID: 2557638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes.
    Kordower JH; Bartus RT; Bothwell M; Schatteman G; Gash DM
    J Comp Neurol; 1988 Nov; 277(4):465-86. PubMed ID: 2850304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
    Schmeichel AM; Buchhalter LC; Low PA; Parisi JE; Boeve BW; Sandroni P; Benarroch EE
    Neurology; 2008 Jan; 70(5):368-73. PubMed ID: 18227417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons.
    Mufson EJ; Bothwell M; Hersh LB; Kordower JH
    J Comp Neurol; 1989 Jul; 285(2):196-217. PubMed ID: 2547849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats.
    Gibbs RB
    Brain Res; 1996 May; 720(1-2):61-8. PubMed ID: 8782897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Tanaka Y; Kanetaka H; Iwamoto T; Abe K
    Neurosci Lett; 2005 May 20-27; 380(1-2):166-9. PubMed ID: 15854771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
    J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.